In a series of tweets, he posts photos, showing potential operating facilities being site visited after the deal struck in the summer with South Africa-based company House of Hemp.
The latter's 405,000 square foot site in the Dube TradePort AgriZone, is the only approved indoor growing site in South Africa, signed off by both the South Africa Department of Agriculture and the Department of Health.
The deal, said Lenigas at the time, launches "LGC straight into the global medical cannabis sector".
John McMullen at Dube TradePort Block D AgriZone at Durban international Airport in South Africa. John is blown away! Absolutely massive. @LGCCapital_LG @Jadmcmullen @CanadaPotstocks @realTheProphet pic.twitter.com/PIhqoqhwxx— David Lenigas (@DavidLenigas) December 14, 2017
In June, a tie-up between AfriAg and LGC was announced, with the partnership setting a stated goal of setting up Africa based cannabis production for export into foreign markets.
In October, Lenigas told Proactive's Andrew Scott that: "We're seeing a global push for legalised cannabis within a full regulatory regime growing dramatically globally."
Last month , the cannabis theme continued with LGC shares booming as it entered what it sees as another growing market - the cannabis infused drinks industry.
The firm, along with Creso Pharma Limited (Australia and Switzerland) and Baltic Beer Company Ltd (UK) have signed a binding LOI (letter of intent) to form a joint venture to develop a bespoke portfolio of cannabis- and hemp-derived alcoholic and non-alcoholic beverages.
The partners added they had already identified potential distribution partners in Europe, far East Asia, Central and Latin America, Canada, Africa and with the recent legalization of hemp seed-based food and drink products in Australia and New Zealand, partners have been identified in this region as well.
LGC Capital shares added over 12% on Thursday to stand at C$0.46 each.